Literature DB >> 2917359

Antigenic differences between metastatic and nonmetastatic BSp73 rat tumor variants characterized by monoclonal antibodies.

S Matzku1, A Wenzel, S Liu, M Zöller.   

Abstract

Variants AS and ASML of the BSp73 rat tumor differ markedly with respect to morphology and to the capacity for spontaneous metastasis via the lymphatics. Monoclonal antibodies (MAbs) were raised in order to identify surface molecules associated with both phenotypes. Mice were immunized with either whole cells or isolated membranes and hybridoma supernatants were screened according to the criteria of selective binding to cultured cells of the variant used for immunization. Of two MAbs reacting with the nonmetastasizing AS variant, one showed immunostaining of AS tissue. From 11 MAbs binding to the metastatic ASML variant, 6 showed specific staining of ASML tissue, while the remaining 5 MAbs showed cross-reaction with normal rat tissues. According to Western blot data, the 6 MAbs selectively binding to ASML tissue identified at least 2 different antigens, one of them showing up as a complex of 12 bands.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2917359

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  24 in total

1.  CD44 is required for two consecutive steps in HGF/c-Met signaling.

Authors:  Véronique Orian-Rousseau; Linfeng Chen; Jonathan P Sleeman; Peter Herrlich; Helmut Ponta
Journal:  Genes Dev       Date:  2002-12-01       Impact factor: 11.361

2.  C4.4A is associated with tumor budding and epithelial-mesenchymal transition of colorectal cancer.

Authors:  Ryota Oshiro; Hirofumi Yamamoto; Hidekazu Takahashi; Masahisa Ohtsuka; Xin Wu; Junichi Nishimura; Ichiro Takemasa; Tsunekazu Mizushima; Masataka Ikeda; Mitsugu Sekimoto; Nariaki Matsuura; Yuichiro Doki; Masaki Mori
Journal:  Cancer Sci       Date:  2012-04-11       Impact factor: 6.716

3.  The tetraspanin D6.1A and its molecular partners on rat carcinoma cells.

Authors:  Christoph Claas; Joachim Wahl; David J Orlicky; Handan Karaduman; Martina Schnölzer; Tore Kempf; Margot Zöller
Journal:  Biochem J       Date:  2005-07-01       Impact factor: 3.857

4.  CD44 functions in Wnt signaling by regulating LRP6 localization and activation.

Authors:  M Schmitt; M Metzger; D Gradl; G Davidson; V Orian-Rousseau
Journal:  Cell Death Differ       Date:  2014-10-10       Impact factor: 15.828

5.  Human lung adenocarcinoma cell lines with different lung colonization potential (LCP), and a correlation between expression of sialosyl dimeric Le(x) (defined by MAb FH6) and LCP.

Authors:  H Inufusa; N Kojima; M Yasutomi; S Hakomori
Journal:  Clin Exp Metastasis       Date:  1991 May-Jun       Impact factor: 5.150

6.  Up-regulation of the tumour-associated marker CD44V6 in experimental kidney disease.

Authors:  K Takazoe; R Foti; G H Tesch; L A Hurst; H Y Lan; R C Atkins; D J Nikolic-Paterson
Journal:  Clin Exp Immunol       Date:  2000-09       Impact factor: 4.330

7.  Antibody transport and internalization into tumours.

Authors:  S Matzku; G Moldenhauer; H Kalthoff; S Canevari; M Colnaghi; J Schuhmacher; H Bihl
Journal:  Br J Cancer Suppl       Date:  1990-07

8.  Sulfated glycoconjugate determinants recognized by monoclonal antibody, SG-1, correlate with the experimental metastatic ability of KHT fibrosarcoma cells.

Authors:  J F Harris; D W Beaton
Journal:  Clin Exp Metastasis       Date:  1990 Jul-Aug       Impact factor: 5.150

9.  Exosomal tumor microRNA modulates premetastatic organ cells.

Authors:  Sanyukta Rana; Kamilla Malinowska; Margot Zöller
Journal:  Neoplasia       Date:  2013-03       Impact factor: 5.715

Review 10.  CD44: physiological expression of distinct isoforms as evidence for organ-specific metastasis formation.

Authors:  M Zöller
Journal:  J Mol Med (Berl)       Date:  1995-09       Impact factor: 4.599

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.